In stable CAD with type 2 diabetes, adding ticagrelor to aspirin reduced CV events but increased major bleeding.

In stable CAD with type 2 diabetes, adding ticagrelor to aspirin reduced CV events but increased major bleeding. Ann Intern Med. 2020 Jan 21;172(2):JC4 Authors: Raco DL PMID: 31958818 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31958818?dopt=Abstract

Source: Annals of Internal Medicine - January 20, 2020 Category: Internal Medicine Authors: Raco DL Tags: Ann Intern Med Source Type: research